{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:39:19Z","timestamp":1770223159840,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aetiology of bladder pain syndrome\/interstitial cystitis is still unknown. Numerous mechanisms have been proposed and treatments targeting various aspects of these are used. This review looks at the existing evidence on bladder instillations and whether they could be used in the treatment of lower urinary tract symptoms as well.<\/jats:p>","DOI":"10.1007\/s00192-020-04303-7","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T11:03:18Z","timestamp":1588330998000},"page":"1387-1392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?"],"prefix":"10.1007","volume":"31","author":[{"given":"Giuseppe Alessandro","family":"Digesu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Visha","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka A.","family":"Bhide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vik","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"issue":"2","key":"4303_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00192-016-3109-2","volume":"28","author":"G Kanter","year":"2017","unstructured":"Kanter G, Volpe KA, Dunivan GC, Cichowski SB, Jeppson PC, Rogers RG, et al. Important role of physicians in addressing psychological aspects of interstitial cystitis\/bladder pain syndrome (IC\/BPS): a qualitative analysis. Int Urogynecol J. 2017;28(2):249\u201356. https:\/\/doi.org\/10.1007\/s00192-016-3109-2.","journal-title":"Int Urogynecol J"},{"issue":"7","key":"4303_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00192-018-3574-x","volume":"29","author":"MH Lee","year":"2018","unstructured":"Lee MH, Chang KM, Tsai WC. Morbidity rate and medical utilization in interstitial cystitis\/painful bladder syndrome. Int Urogynecol J. 2018;29(7):1045\u201350. https:\/\/doi.org\/10.1007\/s00192-018-3574-x.","journal-title":"Int Urogynecol J"},{"issue":"3","key":"4303_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00192-018-3846-5","volume":"30","author":"S Swamy","year":"2019","unstructured":"Swamy S, Kupelian AS, Khasriya R, Dharmasena D, Toteva H, Dehpour T, et al. Cross-over data supporting long-term antibiotic treatment in patients with painful lower urinary tract symptoms, pyuria and negative urinalysis. Int Urogynecol J. 2019;30(3):409\u201314. https:\/\/doi.org\/10.1007\/s00192-018-3846-5.","journal-title":"Int Urogynecol J"},{"issue":"11","key":"4303_CR4","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00192-018-3592-8","volume":"29","author":"A Furuta","year":"2018","unstructured":"Furuta A, Yamamoto T, Igarashi T, Suzuki Y, Egawa S, Yoshimura N. Bladder wall injection of mesenchymal stem cells ameliorates bladder inflammation, overactivity, and nociception in a chemically induced interstitial cystitis-like rat model. Int Urogynecol J. 2018;29(11):1615\u201322. https:\/\/doi.org\/10.1007\/s00192-018-3592-8.","journal-title":"Int Urogynecol J"},{"issue":"7","key":"4303_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00192-017-3547-5","volume":"29","author":"A Furuta","year":"2018","unstructured":"Furuta A, Yamamoto T, Suzuki Y, Gotoh M, Egawa S, Yoshimura N. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder. Int Urogynecol J. 2018;29(7):961\u20136. https:\/\/doi.org\/10.1007\/s00192-017-3547-5.","journal-title":"Int Urogynecol J"},{"key":"4303_CR6","unstructured":"Parsons CL, Koziol JA, Proctor JG, Zupkas P, Argade S. Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms. Can J Urol. 2015;22(2):7739\u201344."},{"issue":"1","key":"4303_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2011.12.014","volume":"161","author":"M Vij","year":"2012","unstructured":"Vij M, Srikrishna S, Cardozo L. Interstitial cystitis: diagnosis and management. Eur J Obstet Gynaecol. 2012;161(1):1\u20137.","journal-title":"Eur J Obstet Gynaecol"},{"key":"4303_CR8","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1067\/mob.2002.127375","volume":"187","author":"CL Parsons","year":"2002","unstructured":"Parsons CL, Dell J, Stanford SJ, et al. The prevalence of interstitial cystitis in gynecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obstet Gynecol. 2002;187:1395\u2013400.","journal-title":"Am J Obstet Gynecol"},{"key":"4303_CR9","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1097\/01.ju.0000181203.82693.95","volume":"174","author":"MT Rosenberg","year":"2005","unstructured":"Rosenberg MT, Hazzard M. Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol. 2005;174:2231\u20134.","journal-title":"J Urol"},{"key":"4303_CR10","first-page":"e46","volume":"124","author":"SA Tirlapur","year":"2016","unstructured":"Tirlapur SA, Birch JV, Carberry CL, Khan KS, Latthe PM, Jha S, et al. Management of bladder pain syndrome. BJOG. 2016;124:e46\u201372.","journal-title":"BJOG"},{"key":"4303_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.urology.2004.08.056","volume":"65","author":"CL Parsons","year":"2005","unstructured":"Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology. 2005;65:45\u20138.","journal-title":"Urology"},{"key":"4303_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.urology.2015.01.021","volume":"85","author":"RA Henry","year":"2015","unstructured":"Henry RA, Morales A, Cahill CM. Beyond a simple anesthetic effect: lidocaine in the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. Urology 2015;85:1025\u201333.","journal-title":"Urology"},{"key":"4303_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","volume":"73","author":"CL Parsons","year":"1994","unstructured":"Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994;73:504\u20137.","journal-title":"Br J Urol"},{"issue":"1","key":"4303_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1743-6109.2011.02542.x","volume":"9","author":"CL Parsons","year":"2012","unstructured":"Parsons CL, Zupakas P, Proctor J, et al. Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis. J Sex Med. 2012;9(1):207\u201312.","journal-title":"J Sex Med"},{"issue":"1","key":"4303_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.urology.2007.09.067","volume":"27","author":"BK Welk","year":"2008","unstructured":"Welk BK, Teichman JM. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology. 2008;27(1):67\u201370.","journal-title":"Urology"},{"issue":"10","key":"4303_CR16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1310\/hpj4810-822","volume":"48","author":"JA Generali","year":"2013","unstructured":"Generali JA, Cada DJ. Intravesical heparin: interstitial cystitis (painful bladder syndrome). Hosp Pharm. 2013;48(10):822\u20134.","journal-title":"Hosp Pharm"},{"issue":"6 Pt 1","key":"4303_CR17","first-page":"1900","volume":"165","author":"R Henry","year":"2001","unstructured":"Henry R, Patterson L, Avery N, et al. Absorption of alkalized intravesical lidocaine in normal and inflamed bladders: a simple method for improving bladder anaesthesia. J Urol. 2001;165(6 Pt 1):1900\u20133.","journal-title":"J Urol"},{"key":"4303_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1464-410X.2008.08162.x","volume":"103","author":"JC Nickel","year":"2009","unstructured":"Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103:910\u20138.","journal-title":"BJU Int"},{"issue":"7","key":"4303_CR19","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00192-016-3213-3","volume":"28","author":"L Mateu","year":"2017","unstructured":"Mateu L, Izquierdo L, Franco A, Costa M, Lawrentschuk N, Alcaraz A. Pain relief after triamcinolone infiltration in patients with bladder pain syndrome with Hunner's ulcers. Int Urogynecol J. 2017;28(7):1027\u201331. https:\/\/doi.org\/10.1007\/s00192-016-3213-3.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"4303_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00192-016-3079-4","volume":"28","author":"W Zhang","year":"2017","unstructured":"Zhang W, Deng X, Liu C, Wang X. Intravesical treatment for interstitial cystitis\/painful bladder syndrome: a network meta-analysis. Int Urogynecol J. 2017;28(4):515\u201325. https:\/\/doi.org\/10.1007\/s00192-016-3079-4.","journal-title":"Int Urogynecol J"},{"issue":"7","key":"4303_CR21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00192-015-2631-y","volume":"26","author":"Y Gao","year":"2015","unstructured":"Gao Y, Liao L. Intravesical injection of botulinum toxin a for treatment of interstitial cystitis\/bladder pain syndrome: 10 years of experience at a single center in China. Int Urogynecol J. 2015;26(7):1021\u20136. https:\/\/doi.org\/10.1007\/s00192-015-2631-y.","journal-title":"Int Urogynecol J"},{"issue":"6","key":"4303_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0022-5347(17)62954-9","volume":"98","author":"BH Stewart","year":"1967","unstructured":"Stewart BH, Persky L, Kiser WS. The use of dimethyl sulfoxide (DMSO) in the treatment of interstitial cystitis. J Urol. 1967;98(6):671\u20132. https:\/\/doi.org\/10.1016\/S0022-5347(17)62954-9.","journal-title":"J Urol"},{"key":"4303_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0022-5347(17)41478-9","volume":"140","author":"R Perez-Marrero","year":"1988","unstructured":"Perez-Marrero R. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988;140:36\u20139.","journal-title":"J Urol"},{"key":"4303_CR24","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/S0022-5347(05)66916-9","volume":"164","author":"R Peeker","year":"2000","unstructured":"Peeker R, Haghsheno MA, Holm\u00e4ng S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J Urol. 2000;164:1912\u20135.","journal-title":"J Urol"},{"key":"4303_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/00365590802671031","volume":"43","author":"J Sairanen","year":"2009","unstructured":"Sairanen J, Leppilahti M, Tammela TL, et al. Evaluation of health-related quality of life in patients with painful bladder syndrome\/interstitial cystitis and the impact of four treatments on it. Scand J Urol Nephrol. 2009;43:212\u20139.","journal-title":"Scand J Urol Nephrol"},{"issue":"9","key":"4303_CR26","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00192-017-3266-y","volume":"28","author":"S Iyer","year":"2017","unstructured":"Iyer S, Lotsof E, Zhou Y, Tran A, Botros C, Sand P, et al. Which bladder instillations are more effective? DMSO vs. bupivacaine\/heparin\/triamcinolone: a retrospective study. Int Urogynecol J. 2017;28(9):1335\u201340. https:\/\/doi.org\/10.1007\/s00192-017-3266-y.","journal-title":"Int Urogynecol J"},{"issue":"7","key":"4303_CR27","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/nau.23204","volume":"36","author":"WF Rawls","year":"2017","unstructured":"Rawls WF, Cox L, Rovner ES. Dimethyl sulfoxide (DMSO) as intravesical therapy for interstitial cystitis\/bladder pain syndrome: a review. Neurourol Urodyn. 2017;36(7):1677\u201384.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"4303_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00192-016-3232-0","volume":"28","author":"YN Lim","year":"2017","unstructured":"Lim YN, Dwyer P, Murray C, Karmakar D, Rosamilia A, Thomas E. Long-term outcomes of intravesical dimethyl sulfoxide\/heparin\/hydrocortisone therapy for interstitial cystitis\/bladder pain syndrome. Int Urogynecol J. 2017;28(7):1085\u20139. https:\/\/doi.org\/10.1007\/s00192-016-3232-0.","journal-title":"Int Urogynecol J"},{"issue":"11","key":"4303_CR29","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00192-019-04038-0","volume":"30","author":"JS Schachar","year":"2019","unstructured":"Schachar JS, Evans RJ, Parks GE, Zambon J, Badlani G, Walker SJ. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis\/bladder pain syndrome. Int Urogynecol J. 2019;30(11):1863\u201370. https:\/\/doi.org\/10.1007\/s00192-019-04038-0.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"4303_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00192-007-0515-5","volume":"19","author":"CR Riedl","year":"2008","unstructured":"Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pfl\u00fcger H. Hyaluronan treatment of interstitial cystitis\/painful bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(5):717\u201321.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"3","key":"4303_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.eururo.2004.10.022","volume":"47","author":"LK Daha","year":"2005","unstructured":"Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pfl\u00fcger H. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol. 2005;47(3):393\u20137 discussion 397.","journal-title":"Eur Urol"},{"issue":"12","key":"4303_CR32","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00192-012-1802-3","volume":"23","author":"YS Lv","year":"2012","unstructured":"Lv YS, Zhou HL, Mao HP, Gao R, Wang YD, Xue XY. Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome\/interstitial cystitis. Int Urogynecol J. 2012;23(12):1715\u201320.","journal-title":"Int Urogynecol J"},{"issue":"6","key":"4303_CR33","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3978\/j.issn.2223-4683.2015.11.04","volume":"4","author":"M Cervigni","year":"2015","unstructured":"Cervigni M. Interstitial cystitis\/bladder pain syndrome and glycosaminoglycans replacement therapy. Transl Androl Urol. 2015;4(6):638\u201342. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2015.11.04.","journal-title":"Transl Androl Urol"},{"issue":"9","key":"4303_CR34","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00192-011-1546-5","volume":"23","author":"D Porru","year":"2012","unstructured":"Porru D, Leva F, Parmigiani A, Barletta D, Choussos D, Gardella B, et al. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome\/interstitial cystitis. Int Urogynecol J. 2012;23(9):1193\u20139.","journal-title":"Int Urogynecol J"},{"issue":"9","key":"4303_CR35","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00192-012-1742-y","volume":"23","author":"M Cervigni","year":"2012","unstructured":"Cervigni M, Natale F, Nasta L, Mako A. Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome\/interstitial cystitis: long-term treatment results. Int Urogynecol J. 2012;23(9):1187\u201392. https:\/\/doi.org\/10.1007\/s00192-012-1742-y.","journal-title":"Int Urogynecol J"},{"issue":"9\u201310","key":"4303_CR36","doi-asserted-by":"publisher","first-page":"E610","DOI":"10.5489\/cuaj.2036","volume":"8","author":"O G\u00fclp\u0131nar","year":"2014","unstructured":"G\u00fclp\u0131nar O, Kay\u0131\u015f A, S\u00fcer E, G\u00f6k\u00e7e M\u0130, G\u00fc\u00e7l\u00fc AG, Ar\u0131kan N. Clinical comparison of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome\/interstitial cystitis. Can Urol Assoc J. 2014;8(9\u201310):E610\u20134.","journal-title":"Can Urol Assoc J"},{"issue":"11","key":"4303_CR37","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00192-019-04036-2","volume":"30","author":"B Arslan","year":"2019","unstructured":"Arslan B, G\u00f6n\u00fclta\u015f S, G\u00f6kmen E, \u00d6zman O, Avci MA, \u00d6zdemir E. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid\/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome. Int Urogynecol J. 2019;30(11):1857\u201362. https:\/\/doi.org\/10.1007\/s00192-019-04036-2.","journal-title":"Int Urogynecol J"},{"key":"4303_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1046\/j.1464-410X.1997.03384.x","volume":"79","author":"JJ Bade","year":"1997","unstructured":"Bade JJ, Laseur M, Nieuwenburg A, et al. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol. 1997;79:168\u201371.","journal-title":"Br J Urol"},{"key":"4303_CR39","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00192-008-0560-8","volume":"19","author":"LK Daha","year":"2008","unstructured":"Daha LK, Lazar D, Simak R, et al. The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome\/interstitial cystitis: preliminary results. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:987\u201390.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"3","key":"4303_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00192-018-3850-9","volume":"30","author":"TJ Ferguson","year":"2019","unstructured":"Ferguson TJ, Geraets RL, Barker MA. Chronic use of pentosan polysulfate sodium associated with risk of vision-threatening disease. Int Urogynecol J. 2019;30(3):337\u20138. https:\/\/doi.org\/10.1007\/s00192-018-3850-9.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"4303_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.juro.2007.08.170","volume":"179","author":"EL Davis","year":"2008","unstructured":"Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol. 2008;179(1):177\u201385.","journal-title":"J Urol"},{"issue":"11","key":"4303_CR42","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00192-019-03970-5","volume":"30","author":"J Pape","year":"2019","unstructured":"Pape J, Falconi G, De Mattos Lourenco TR, Doumouchtsis SK, Betschart C. Variations in bladder pain syndrome\/interstitial cystitis (IC) definitions, pathogenesis, diagnostics and treatment: a systematic review and evaluation of national and international guidelines. Int Urogynecol J. 2019;30(11):1795\u20131805. https:\/\/doi.org\/10.1007\/s00192-019-03970-5.","journal-title":"Int Urogynecol J"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04303-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-020-04303-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04303-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:27:28Z","timestamp":1620044848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-020-04303-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4303"],"URL":"https:\/\/doi.org\/10.1007\/s00192-020-04303-7","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"4 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}